28 Jan 2022 , 01:56 PM
Net profit of ERIS Lifesciences rose 11.78% to Rs 100.77 crore in the quarter ended December 2021 as against Rs 90.15 crore during the previous quarter ended December 2020. Sales rose 7.55% to Rs 328.07 crore in the quarter ended December 2021 as against Rs 305.04 crore during the previous quarter ended December 2020.
Particulars | Quarter Ended | ||
? | Dec. 2021 | Dec. 2020 | % Var. |
Sales | 328.07 | 305.04 | 8 |
OPM % | 37.10 | 35.15 | – |
PBDT | 125.86 | 109.90 | 15 |
PBT | 108.98 | 99.30 | 10 |
NP | 100.77 | 90.15 | 12 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.